InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

Current share price for ACL : $2.930 0.01 (0.34%)+

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$547 Change in substantial holding 15 Aug 2022 4:18PM $4.870 $2.930 fallen by 39.84%
$547 Second letter from Crescent Capital 12 Aug 2022 6:57PM $4.880 $2.930 fallen by 39.96%
$547 Letter received from Crescent Capital 12 Aug 2022 6:52PM $4.880 $2.930 fallen by 39.96%
$547 Dividend/Distribution - ACL 10 Aug 2022 8:51AM $5.250 $2.930 fallen by 44.19%
$547 FY22 Investor Presentation 10 Aug 2022 8:21AM $5.250 $2.930 fallen by 44.19%
$547 FY22 Financial Statements 10 Aug 2022 8:20AM $5.250 $2.930 fallen by 44.19%
$547 Appendix 4E - Preliminary Financial Report 10 Aug 2022 8:20AM $5.250 $2.930 fallen by 44.19%
$547 FY22 financial results - investor presentation webinar 4 Aug 2022 2:32PM $5.335 $2.930 fallen by 45.08%
$547 Release of Share from Voluntary Escrow 4 Aug 2022 2:14PM $5.360 $2.930 fallen by 45.34%
$547 Response to Market Enquiries 6 Jun 2022 9:23AM $5.030 $2.930 fallen by 41.75%
$547 Presentation to ASA Conference 23 May 2022 10:20AM $5.700 $2.930 fallen by 48.60%
$547 Change of Director's Interest Notice 28 Apr 2022 6:23PM $5.030 $2.930 fallen by 41.75%
$547 Change of Director's Interest Notice 28 Apr 2022 5:19PM $5.030 $2.930 fallen by 41.75%
$547 Change of Director's Interest Notice 28 Apr 2022 5:13PM $5.030 $2.930 fallen by 41.75%
$547 Update - Dividend/Distribution - ACL 21 Apr 2022 8:11AM $5.290 $2.930 fallen by 44.61%
$547 Becoming a substantial holder 20 Apr 2022 4:54PM $5.290 $2.930 fallen by 44.61%
$547 S&P DJI Announces March 2022 Quarterly Rebalance 4 Mar 2022 5:02PM $4.670 $2.930 fallen by 37.26%
$547 Change of Director's Interest Notice 28 Feb 2022 10:37AM $4.670 $2.930 fallen by 37.26%
$547 Establishment of Dividend Reinvestment Plan 24 Feb 2022 7:58AM $5.030 $2.930 fallen by 41.75%
$547 Dividend/Distribution - ACL 24 Feb 2022 7:58AM $5.030 $2.930 fallen by 41.75%
$547 1H22 Investor Presentation 24 Feb 2022 7:56AM $5.030 $2.930 fallen by 41.75%
$547 Media Release - 1H22 Financial Results 24 Feb 2022 7:56AM $5.030 $2.930 fallen by 41.75%
$547 Appendix 4D 24 Feb 2022 7:56AM $5.030 $2.930 fallen by 41.75%
$547 Release of Shares from Voluntary Escrow 15 Feb 2022 5:16PM $4.730 $2.930 fallen by 38.05%
$547 1H22 Financial Results release details 2 Feb 2022 2:22PM $5.080 $2.930 fallen by 42.32%

601 - 625 of 1030 results

Page 25 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.